Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
2017 1
2021 1
2022 5
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean gorin ma (317 results)?
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. Ridker PM, et al. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28845751 Free article. Clinical Trial.
Guideline based eligibility for primary prevention statin therapy - Insights from the North India ST-elevation myocardial infarction registry (NORIN-STEMI).
Arora S, Qamar A, Gupta P, Hendrickson M, Singh A, Vaduganathan M, Pandey A, Bansal A, Batra V, Mukhopadhyay S, Yusuf J, Tyagi S, Girish MP, Kaul P, Bhatt DL, Gupta M. Arora S, et al. J Clin Lipidol. 2022 Mar-Apr;16(2):227-236. doi: 10.1016/j.jacl.2021.12.001. Epub 2021 Dec 22. J Clin Lipidol. 2022. PMID: 34996741
OBJECTIVE: To assess eligibility for primary prevention statin therapy using the 2018 U.S Multisociety Guideline and other contemporary cholesterol guidelines in patients presenting with ST-elevation myocardial infarction (STEMI) in the North India STEMI (NORIN-STEMI) regi …
OBJECTIVE: To assess eligibility for primary prevention statin therapy using the 2018 U.S Multisociety Guideline and other contemporary chol …
Machine learning based model for risk prediction after ST-Elevation myocardial infarction: Insights from the North India ST elevation myocardial infarction (NORIN-STEMI) registry.
Shetty MK, Kunal S, Girish MP, Qamar A, Arora S, Hendrickson M, Mohanan PP, Gupta P, Ramakrishnan S, Yadav R, Bansal A, Zachariah G, Batra V, Bhatt DL, Gupta A, Gupta M. Shetty MK, et al. Int J Cardiol. 2022 Sep 1;362:6-13. doi: 10.1016/j.ijcard.2022.05.023. Epub 2022 May 13. Int J Cardiol. 2022. PMID: 35577162
BACKGROUND: Risk prediction following ST-Elevation Myocardial Infarction (STEMI) in resource limited countries is critical to identify patients at an increased risk of mortality who might benefit from intensive management. METHODS: North India ST-Elevation Myocardial Infarction ( …
BACKGROUND: Risk prediction following ST-Elevation Myocardial Infarction (STEMI) in resource limited countries is critical to identify patie …
Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI Registry.
Ostrominski JW, Vaduganathan M, Girish MP, Gupta P, Hendrickson MJ, Qamar A, Arora S, Pandey A, Bansal A, Batra V, Mahajan B, Mukhopadhyay S, Yusuf J, Tyagi S, Bhatt DL, Gupta MD; NORIN STEMI Investigators. Ostrominski JW, et al. Glob Heart. 2022 Aug 12;17(1):54. doi: 10.5334/gh.1140. eCollection 2022. Glob Heart. 2022. PMID: 36051328 Free PMC article.
We evaluated the impact of protocolized screening for dysglycemia on the prevalence of prediabetes and diabetes among patients presenting with ST-segment elevation myocardial infarction (STEMI) in North India. METHODS: We conducted a prospective NORIN STEMI registry-based …
We evaluated the impact of protocolized screening for dysglycemia on the prevalence of prediabetes and diabetes among patients presenting wi …
Benefit Versus Risk Assessment of Melflufen and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Analyses From Longer Follow-up of the OCEAN and HORIZON Studies.
Sonneveld P, Richardson PG, Ludwig H, Dimopoulos MA, Schjesvold FH, Hájek R, Abdulhaq H, Thuresson M, Norin S, Bakker NA, Mateos MV. Sonneveld P, et al. Clin Lymphoma Myeloma Leuk. 2023 Sep;23(9):687-696. doi: 10.1016/j.clml.2023.05.004. Epub 2023 May 6. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37355418 Free article.
Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study.
Pour L, Szarejko M, Bila J, Schjesvold FH, Spicka I, Maisnar V, Jurczyszyn A, Grudeva-Popova Z, Hájek R, Usenko G, Thuresson M, Norin S, Jarefors S, Bakker NA, Richardson PG, Mateos MV. Pour L, et al. Haematologica. 2024 Mar 1;109(3):895-905. doi: 10.3324/haematol.2023.283509. Haematologica. 2024. PMID: 37646660 Free PMC article. Clinical Trial.
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study.
Ocio EM, Efebera YA, Hájek R, Straub J, Maisnar V, Eveillard JR, Karlin L, Mateos MV, Oriol A, Ribrag V, Richardson PG, Norin S, Obermüller J, Bakker NA, Pour L. Ocio EM, et al. Haematologica. 2024 Mar 1;109(3):867-876. doi: 10.3324/haematol.2023.283490. Haematologica. 2024. PMID: 37646657 Free PMC article. Clinical Trial.
Prevalence and prognostic implications of reduced left ventricular ejection fraction among patients with STEMI in India.
Hendrickson MJ, Arora S, Vaduganathan M, Fonarow GC, Mp G, Bansal A, Batra V, Kunal S, Bhatt DL, Gupta M, Qamar A. Hendrickson MJ, et al. ESC Heart Fail. 2022 Dec;9(6):3836-3845. doi: 10.1002/ehf2.14055. Epub 2022 Aug 10. ESC Heart Fail. 2022. PMID: 35950269 Free PMC article.
METHODS AND RESULTS: Adults presenting with STEMI to two government-owned tertiary care centres in Delhi, India were prospectively enrolled in the North India ST-elevation myocardial infarction (NORIN-STEMI) registry. LVEF was evaluated at presentation and clinical charact …
METHODS AND RESULTS: Adults presenting with STEMI to two government-owned tertiary care centres in Delhi, India were prospectively enrolled …
Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study.
Schjesvold FH, Ludwig H, Delimpasi S, Robak P, Coriu D, Tomczak W, Pour L, Spicka I, Dimopoulos MA, Masszi T, Chernova NG, Sandberg A, Thuresson M, Norin S, Bakker NA, Mateos MV, Richardson PG, Sonneveld P. Schjesvold FH, et al. Haematologica. 2024 Feb 29. doi: 10.3324/haematol.2023.284635. Online ahead of print. Haematologica. 2024. PMID: 38426292 Free article.
11 results